The early contribution of cerebrovascular factors to the pathogenesis of Alzheimer's disease

被引:75
|
作者
Pimentel-Coelho, Pedro M.
Rivest, Serge [1 ]
机构
[1] Univ Laval, CHUQ Res Ctr CHUL, Lab Endocrinol & Genom, Quebec City, PQ G1V 4G2, Canada
基金
加拿大健康研究院;
关键词
angiogenesis; cerebral ischemia; chronic cerebral hypoperfusion; neurogenesis; stroke; AMYLOID PRECURSOR PROTEIN; TRANSGENIC MOUSE MODEL; CEREBRAL-BLOOD-FLOW; MILD COGNITIVE IMPAIRMENT; COLONY-STIMULATING FACTOR; ENDOTHELIAL GROWTH-FACTOR; WHITE-MATTER LESIONS; CIRCULATING ANGIOGENIC CELLS; CAROTID-ARTERY OCCLUSION; MARROW-DERIVED MICROGLIA;
D O I
10.1111/j.1460-9568.2012.08126.x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alzheimers disease (AD) and cerebrovascular disorders are the leading causes of dementia in our ageing population. Given that the progression of neuropathological changes in the brains of AD patients initiates several years, and even decades, before the diagnosis of dementia, a great effort has been made to identify potentially modifiable factors that contribute to the pathogenesis of sporadic late-onset AD. Among these factors, cerebrovascular disease and microvascular alterations seem to bilaterally interact with the underlying AD pathology, affecting the progression of cognitive deficits. In addition, cerebrovascular dysfunction has emerged as an early event in AD, encompassing changes in virtually all cell types of the neurovascular unit, including bone marrow-derived cells, astrocytes, pericytes, vascular smooth muscle cells and endothelial cells. In this review, we discuss recent studies implicating cerebrovascular factors in the pathogenesis of AD. We also discuss how the impairment of mechanisms of brain regeneration, such as neurogenesis and angiogenesis, might be related to the vascular dysfunction. Finally, we briefly discuss several therapeutic options targeting the vascular system, which might represent an interesting strategy for preventing or delaying the onset of dementia in AD.
引用
收藏
页码:1917 / 1937
页数:21
相关论文
共 50 条
  • [41] Cerebrovascular damage as a cause for Alzheimer's disease
    Humpel, C
    Marksteiner, J
    CURRENT NEUROVASCULAR RESEARCH, 2005, 2 (04) : 341 - 347
  • [42] Comorbidity of Cerebrovascular and Alzheimer's Disease in Aging
    Xia, Ying
    Yassi, Nawaf
    Raniga, Parnesh
    Bourgeat, Pierrick
    Desmond, Patricia
    Doecke, James
    Ames, David
    Laws, Simon M.
    Fowler, Christopher
    Rainey-Smith, Stephanie R.
    Martins, Ralph
    Maruff, Paul
    Villemagne, Victor L.
    Masters, Colin L.
    Rowe, Christopher C.
    Fripp, Jurgen
    Salvado, Olivier
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 78 (01) : 321 - 334
  • [43] CEREBROVASCULAR AND CARDIOVASCULAR PATHOLOGY IN ALZHEIMER'S DISEASE
    de la Torre, Jack C.
    NEUROBIOLOGY OF DEMENTIA, 2009, 84 : 35 - +
  • [44] COMAJ (Early onset Alzheimer's disease cohort): Vascular risk factors impact on early onset Alzheimer's disease
    Maureille, A.
    Sillaire, A. Rollin
    Chen, Y.
    Skrobala, E.
    Pasquier, F.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 105 - 105
  • [45] Alzheimer disease and Down syndrome: factors in pathogenesis
    Lott, IT
    Head, E
    NEUROBIOLOGY OF AGING, 2005, 26 (03) : 383 - 389
  • [46] Mitochondria in Alzheimer's Disease Pathogenesis
    Reiss, Allison B.
    Gulkarov, Shelly
    Jacob, Benna
    Srivastava, Ankita
    Pinkhasov, Aaron
    Gomolin, Irving H.
    Stecker, Mark M.
    Wisniewski, Thomas
    De Leon, Joshua
    LIFE-BASEL, 2024, 14 (02):
  • [47] Microglia and Alzheimer's disease pathogenesis
    Streit, WJ
    JOURNAL OF NEUROSCIENCE RESEARCH, 2004, 77 (01) : 1 - 8
  • [48] Alzheimer's disease: A hypothesis on pathogenesis
    Harman, D
    JOURNAL OF THE AMERICAN AGING ASSOCIATION, 2000, 23 (03) : 147 - 161
  • [49] Molecular pathogenesis of Alzheimer's disease
    Iwatsubo, T
    INTERNAL MEDICINE, 2003, 42 (03) : 312 - 312
  • [50] Complement in the pathogenesis of Alzheimer’s disease
    B. Paul Morgan
    Seminars in Immunopathology, 2018, 40 : 113 - 124